At the Edge of a Miracle: The Hepatitis C Virus (HCV) Epidemic in Malaysia
The hepatitis C virus (HCV) has long since been a neglected disease. However, of late, given the development of revolutionary drugs called direct-acting antivirals (DAAs) that can cure the disease in as little as 8 weeks, international interest, and with it, international financial investment, has peaked.
When we began this project, we realised that there was little consolidated information on the HCV situation in Malaysia, whether epidemiological reports, patient voices, or the diagnostics and treatment environment. This report seeks to fill that gap and be a useful tool for clinicians, civil society, policymakers, politicians, and other stakeholders working towards access and affordability of HCV diagnostics and medication.